Page 2 - Shane Olwill News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Shane olwill. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Shane Olwill Today - Breaking & Trending Today

Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces Presentation of Preclinical Data for Inhaled Jagged-1 Inhibitor PRS-400 at ERS

BOSTON, MA / ACCESSWIRE / August 24, 2022 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology ....

United States , Maria Kelman , Shane Olwill , Pieris Pharmaceuticals , Company Quarterly Reports On Form , Exchange Commission , Company Annual Report On Form , International Congress , European Respiratory Society , Securities Exchange , Pieris Pharmaceuticals Inc , Chief Development Officer , Looking Statements , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports , Relations Contact ,

Pieris Pharmaceuticals Announces Presentation of Preclinical Data for Inhaled Jagged-1 Inhibitor PRS-400 at ERS

Pieris Pharmaceuticals Announces Presentation of Preclinical Data for Inhaled Jagged-1 Inhibitor PRS-400 at ERS
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

United States , Maria Kelman , Shane Olwill , Pieris Pharmaceuticals , Company Quarterly Reports On Form , Exchange Commission , Company Annual Report On Form , International Congress , European Respiratory Society , Securities Exchange , Pieris Pharmaceuticals Inc , Chief Development Officer , Looking Statements , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports , Relations Contact , United States Wire Group ,

Pieris Pharmaceuticals, Inc (PIRS) CEO Stephen S. Yoder on Q1 2022 Results - Earnings Call Transcript

Pieris Pharmaceuticals, Inc (NASDAQ:NASDAQ:PIRS) Q1 2022 Earnings Conference Call May 11, 2022, 8:00 AM ET Company Participants Stephen S. ....

United States , Shane Olwill , Jessica Hanitta Hui , Stephen Yoder , Ilse Aigner , Stephens Yoder , Tim Demuth , Matthew Phipps , John Miller , Thomas Bures , Hitto Kaufmann , William Blair , Company Participants , William Blair Company , Boston Pharmaceuticals , Pieris Pharmaceuticals Inc , Pieris Pharmaceuticals , Conference Call May , Chief Executive Officer , Senior Vice President , Chief Financial , Chief Medical , Hanitta Hui , Jiale Song , First Quarter Earnings , Chief Medical Officer ,

Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces PRS-220 Presentation at ERS Highlighting Preclinical Data for CTGF Inhibitor

Pieris Pharmaceuticals, Inc.: Pieris Pharmaceuticals Announces PRS-220 Presentation at ERS Highlighting Preclinical Data for CTGF Inhibitor
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Maria Kelman , Shane Olwill , Drug Administration , Pieris Pharmaceuticals , Company Quarterly Reports On Form , Exchange Commission , Company Annual Report On Form , International Congress , European Respiratory Society , Securities Exchange , Pieris Pharmaceuticals Inc , Chief Development Officer , Looking Statements , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports , Relations Contact ,

Pieris Pharmaceuticals Announces PRS-220 Presentation at ERS Highlighting Preclinical Data for CTGF Inhibitor

Pieris Pharmaceuticals Announces PRS-220 Presentation at ERS Highlighting Preclinical Data for CTGF Inhibitor
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

United States , Maria Kelman , Shane Olwill , Drug Administration , Pieris Pharmaceuticals , Company Quarterly Reports On Form , Exchange Commission , Company Annual Report On Form , International Congress , European Respiratory Society , Securities Exchange , Pieris Pharmaceuticals Inc , Chief Development Officer , Looking Statements , Securities Act , Securities Exchange Act , Annual Report , Quarterly Reports , Relations Contact ,